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Key question
What is already known?
 ► Previous cross-sectional studies have identified key 
risk factors for stunted growth, including being small 
for gestational age at birth, poor sanitation, child-
hood diarrhoea, and low dietary diversity and infre-
quent infant feeding.
What are the new findings?
 ► We found consistent associations of 18-month 
length-for-age z-scores (LAZ) with maternal height 
and maternal body mass index.
 ► The factors with the strongest associations with 
18-month LAZ were length for gestational age 
z-score (LGAZ) at birth, maternal height and gesta-
tional age at birth.
 ► Other factors that showed significant associations 
with 18-month LAZ (although with smaller coeffi-
cients), were improved household water source, child 
dietary diversity, childhood diarrhoea incidence and 
6-month or 9-month haemoglobin concentration.
What do the new findings imply?
 ► Interventions targeting these factors associated 
with LAZ may accelerate progress towards reduc-
ing stunting; however, much of the variance in linear 
growth status remained unaccounted for by individ-
ual-level factors, suggesting that community-level 
changes may be needed to achieve substantial prog-
ress and further research is needed to understand 
the causes of stunting.
AbsTrACT
Stunting prevalence is an indicator of a country’s progress 
towards United Nations’ Sustainable Development Goal 
2, which is to end hunger and achieve improved nutrition. 
Accelerating progress towards reducing stunting requires 
a deeper understanding of the factors that contribute 
to linear growth faltering. We conducted path analyses 
of factors associated with 18-month length-for-age 
z-score (LAZ) in four prospective cohorts of children who 
participated in trials conducted as part of the International 
Lipid-Based Nutrient Supplements Project in Ghana 
(n=1039), Malawi (n=684 and 1504) and Burkina Faso 
(n=2619). In two cohorts, women were enrolled during 
pregnancy. In two other cohorts, infants were enrolled 
at 6 or 9 months. We examined the association of 42 
indicators of environmental, maternal, caregiving and 
child factors with 18-month LAZ. Using structural equation 
modelling, we examined direct and indirect associations 
through hypothesised mediators in each cohort. Out of 42 
indicators, 2 were associated with 18-month LAZ in three 
or four cohorts: maternal height and body mass index 
(BMI). Six factors were associated with 18-month LAZ 
in two cohorts: length for gestational age z-score (LGAZ) 
at birth, pregnancy duration, improved household water, 
child dietary diversity, diarrhoea incidence and 6-month or 
9-month haemoglobin concentration. Direct associations 
were more prevalent than indirect associations, but 
30%–62% of the associations of maternal height and 
BMI with 18-month LAZ were mediated by LGAZ at birth. 
Factors that were not associated with LAZ were maternal 
iron status, illness and inflammation during pregnancy, 
maternal stress and depression, exclusive breast feeding 
during 6 months post partum, feeding frequency and child 
fever, malaria and acute respiratory infections. These 
findings may help in identifying interventions to accelerate 
progress towards reducing stunting; however, much of the 
variance in linear growth status remained unaccounted 
for by these 42 individual-level factors, suggesting that 
community-level changes may be needed to achieve 
substantial progress.
InTroduCTIon
Linear growth faltering during early life is 
associated with later health conditions, such 
as cardiometabolic disease,1 and poor cogni-
tive and school performance.2 Stunting 
occurs when children falter in linear growth 
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early in life and is defined as height-for-age >2 SD 
below the median of the WHO Child Growth Stand-
ards.3 Stunting prevalence is an important indicator to 
evaluate a country’s progress towards United Nations’ 
Sustainable Development Goal 2, which is to end 
hunger and achieve improved nutrition by 2030. From 
2000 to 2017, the estimated number of stunted chil-
dren under 5 years of age globally decreased from 198 
million to 151 million.4 Accelerating progress towards 
reducing the prevalence of stunting requires a more 
advanced understanding of the factors that contribute 
to early linear growth faltering.
Several previous reviews have summarised these risk 
factors,5–7 identifying environmental factors such as 
household food insecurity and poor quality water and 
sanitation; maternal factors such as short stature and 
poor nutrition and health during pregnancy; care-
giving factors, such as infrequent feeding and low 
dietary diversity; and child factors such as being born 
preterm, small for gestational age and childhood diar-
rhoea incidence. Frameworks that describe the deter-
minants of childhood malnutrition5 6 recognise that 
distal factors (eg, community, household level) operate 
through more proximal factors (eg, maternal, child 
level) in their influence on growth faltering. However, 
most studies that have attempted to quantify the rela-
tive contribution of risk factors for linear growth 
faltering have used cross-sectional analyses, such as 
the estimation of regression coefficients8–10 or popula-
tion-attributable fraction.11 12 These methods describe 
direct associations, but do not account for the indirect 
associations of distal factors through proximal factors.
In the current study, we performed a set of path anal-
yses of factors associated with linear growth status at 
age 18 months in four longitudinal cohorts of children 
(n=5846) who participated in the International Lipid-
Based Nutrient Supplements (iLiNS) Project in Ghana, 
Malawi and Burkina Faso. The first objective was to 
identify the factors associated with 18-month linear 
growth status, reflecting cumulative linear growth 
during gestation and the first 18 months after birth, in 
each iLiNS cohort. The second objective was to identify 
the pathways through which these factors operate. The 
prospective design enabled examination of factors asso-
ciated with linear growth throughout most of the first 
1000 days after conception. Harmonisation of many of 
the variables across cohorts allowed examination of the 
same factors and pathways in different contexts.
Finally, our third objective was to determine whether 
a pooled analysis examining predictors of 18-month 
length-for-age z-score (LAZ) across cohorts accounted 
for more variance in LAZ than the within-cohort 
models. Evidence suggests that linear growth faltering 
is a whole-population phenomenon. In populations 
with a high prevalence of stunting, it is not the case 
that a subgroup of that population is faltering while the 
rest are growing normally, but instead there is usually 
a downward shift in the entire height distribution of 
the population.13 If between-population differences are 
more meaningful than within-population differences 
between individuals, then we would expect the pooled 
analysis to account for more variance than the analyses 
of each separate cohort.
MeTHods
Based on several previous frameworks,5 6 14 we devel-
oped a conceptual path model of potential influences 
on 18-month linear growth status (figure 1). We tested 
the following pathways, which correspond to the labels 
of the arrows in figure 1.
Pathway (1)
At an individual level, maternal height may be related 
to the child’s genetic potential for adult height that can 
be attained. In populations with a high prevalence of 
stunting, maternal height is also partly a reflection of 
growth restriction experienced by the mother during 
early life. Therefore, inclusion of maternal height 
in the model served two purposes: first, to adjust for 
a proxy of genetic potential, and second, to test the 
pathway that intergenerational effects of maternal 
growth during early life, reflected by maternal adult 
height, on child linear growth may be mediated by 
(1.1) socioeconomic conditions of the current gener-
ation, (1.2) maternal adult factors (nutritional status, 
illness, stress, depression, cognition), (1.3) caregiving 
practices, (1.4) child factors or (1.5) may directly affect 
linear growth (arrows for each individual pathway not 
drawn in the figure).
Pathway (2)
Socioeconomic disparities and other environmental 
effects on child linear growth may be mediated by (2.1) 
maternal factors, (2.2) caregiving practices, (2.3) child 
factors or (2.4) may directly affect linear growth.
Pathway (3)
Effects of maternal factors on child growth may be 
mediated by (3.1) child factors, (3.2) caregiving prac-
tices or (3.3) may directly affect child growth.
Pathway (4)
Effects of infant feeding practices on child growth may 
be mediated by child factors (4.1) or caregiving prac-
tices may directly affect child growth (4.2).
Pathway (5)
Effects of preterm birth or intrauterine growth restric-
tion on later child linear growth status may be medi-
ated by (5.1) postnatal child factors (appetite, illness, 
haemoglobin (Hb)/iron status, physical activity, stress) 
or (5.2) may be direct effects.
Pathway (6)
Effects of child factors (appetite, illness, Hb/iron 
status, physical activity, stress) on child growth (6.1) 
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Figure 1 Conceptual model.
may be mediated by caregiving behaviour in response 
to these factors, or (6.2) may be direct effects.
iLiNS project trial designs
In the iLiNS-DYAD-G trial in Ghana (n=1320) and the 
iLiNS-DYAD-M trial in Malawi (n=869), pregnant women 
were enrolled at ≤20 weeks of gestation. In the iLiNS-
DOSE trial in Malawi (n=1932) and iLiNS-ZINC trial in 
Burkina Faso (n=3220), infants were enrolled at age 6 
and 9 months, respectively. All participants were assigned 
to receive various doses and formulations of lipid-based 
nutrient supplements (LNS), or to control groups until 
age 18 months, when length was measured.15–18 The 
effects of the interventions on 18-month child length-for 
LAZ differed across trials, with positive effects in Burkina 
Faso17 and Ghana,15 but not in Malawi.16 18 For further 
information, see supplemental methods.
Participants
In the path analyses reported here, we included all 
children for whom LAZ at age 18 months was available, 
comprising 1039 children in iLiNS-DYAD-G, 684 in 
iLiNS-DYAD-M, 1504 in iLiNS-DOSE and 2619 children 
in iLiNS-ZINC.
Procedure
Detailed reports of the data collection procedures in 
each trial have been published elsewhere15–18; there-
fore, we summarise the procedures for collection of 
variables that were used in the analyses presented here. 
Online supplementary table 1 presents further details 
of the data collection procedures and variable defini-
tions. Figure 2 shows the data collection schedule for 
each variable in each cohort.
Data on socio-demographic characteristics and 
maternal anthropometric status were gathered at enrol-
ment. In the two DYAD trials, maternal pre-pregnancy 
body mass index (BMI) was estimated based on BMI 
and gestational age at enrolment. Capillary or venous 
blood samples were collected from mothers and/or 
children at multiple time points for the assessment of 
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Figure 2 Data collection timeline in each cohort.
(1) malaria using a rapid diagnostic test, (2) Hb concen-
tration (g/L), (3) biomarkers of iron status, including 
zinc protoporphyrin (ZPP) concentration (μmol/mol 
heme), and soluble transferrin receptor (sTfR, mg/L), 
and (4) biomarkers of inflammation, including alpha-
1-acid glycoprotein (AGP; g/L) concentration. In 
ZINC, known HIV infection was an exclusion criterion, 
but HIV was not tested; therefore, HIV status of women 
who were enrolled was unknown. In DOSE, HIV status 
was also unknown. In DYAD-G, HIV infection was 
known from antenatal cards and HIV-positive women 
were excluded. In DYAD-M, women were tested for HIV 
at enrolment but were not excluded.
Maternal and/or child saliva samples in DYAD-M 
and DYAD-G were collected at several time points for 
the measurement of cortisol concentration (nmol/L). 
Maternal self-reported stress was measured in DYAD-M 
at multiple time points using the Perceived Stress 
Scale.19 20 Mothers were interviewed regarding depres-
sive symptoms at 6 months post partum in DYAD-M 
using a locally validated adaptation of the Self-Re-
porting Questionnaire and in DYAD-G with the Edin-
burgh Post-natal Depression Scale.21 In DYAD-M, at 6 
months post partum, maternal cognition was assessed 
using digit span forward and backward, verbal fluency, 
mental rotation and functional health literacy tests.22
Children were visited weekly for morbidity surveil-
lance. At these visits, caregivers were asked whether 
the child experienced any illness symptoms, including 
fever, diarrhoea, vomiting, cough, nasal discharge, 
respiratory distress or poor appetite during the past 
seven days and/or data collectors measured the child’s 
auricular temperature. Longitudinal prevalence and/
or incidence of diarrhoea, fever, malaria, acute respi-
ratory infection and/or poor appetite were calculated 
(online supplementary table 1). In DOSE and DYAD-M, 
physical activity at age 18 months was measured over 
1 week with the hip-worn ActiGraph GT3X+accelerom-
eter (Pensacola, Florida, USA).23
Infant feeding practices were assessed at multiple 
time points through qualitative 24 hours and/or 7-day 
dietary recall questionnaires.24 In all four trials, devel-
opmental stimulation was measured at age 18 months 
using the Family Care Indicators interview.25 The 
mother was interviewed with regard to the variety of 
play materials and activities that adults used to engage 
with the child in the past three days.
In DYAD-G and DYAD-M, gestational age at enrolment 
was mainly determined by ultrasound and this was used 
to calculate gestational age at birth. In DYAD-G, infant 
weight and length were measured within 48 hours of 
birth or between 3 and 14 days after birth for 87 (9.4%) 
when the former was not possible. In DYAD-M, infant 
weight and length were measured within 6 weeks of 
birth. We estimated length and weight at birth based 
on LAZ and WAZ measured within 6 weeks of birth, 
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Figure 3 Mediation analysis.
assuming that LAZ and WAZ did not change from birth 
to the time of measurement. Length and weight for 
gestational age at birth z-scores were then calculated 
based on the INTERGROWTH-21st standards.26 In all 
four cohorts, length was measured at age 18 months. All 
length measurements were conducted to the nearest 1 
mm by teams of two trained and standardised anthro-
pometrists using length boards.
Analysis
We examined the distribution of each independent 
variable separately by cohort. We log-transformed 
skewed variables and winsorised outliers to the 1st and 
99th percentile. If transformation did not result in a 
normal distribution, we created a binary variable. All 
continuous variables were standardised to SD units by 
subtracting the mean and dividing by SD.
We performed exploratory mediation analyses 
according to the following steps. We refer to figure 3 to 
describe each step in the mediation analysis.
Step 1: variable selection
The first condition for inclusion in our mediation 
analysis was that X is associated with Y, represented 
by c in figure 3, so we examined independent associ-
ations between each predictor and 18-month LAZ and 
dropped any that were not associated at p<0.05. The 
second condition was that X is associated with M, repre-
sented by a. The third condition was that M is associ-
ated with Y, represented by b. In this first step, we tested 
the significance of b and c.
Second, we reduced the number of variables 
measuring the same construct by eliminating vari-
ables that were collinear. If two variables were highly 
collinear (r>0.6), we dropped the one that was less 
strongly associated with 18-month LAZ. Third, we 
examined four multivariate models with each cate-
gory of factors together predicting 18-month LAZ and 
dropped any that were not associated at p<0.05. If, at 
this step, no variable was significantly associated when 
controlling for the others, we retained the one that was 
most strongly associated with 18-month LAZ. The four 
multivariate models were (1) all environmental factors 
together, (2) all maternal factors together, excluding 
maternal height, (3) all caregiving factors together and 
(4) all child factors together, excluding gestational age 
at birth and LGAZ at birth.
Step 2: path selection
For each pathway in figure 1, we examined the asso-
ciation between each pair of variables on the pathway 
to determine which variables were potential mediators. 
In this second step, we tested the significance of a in 
figure 3 and dropped any pathways for which p>0.05. 
In figure 1, unidirectional arrows represent pathways 
tested. Bidirectional arrows represent associations that 
were checked for collinearity, but were not otherwise 
modelled in the path analysis. All analyses up to this 
point were conducted using SAS V.9.4 (SAS Institute). 
Next, for each independent variable with potential 
mediators, we tested the mediation model using Stata 
V.14.1 (StataCorp) binary mediation program. We ran 
the multiple mediation model including all potential 
mediators together, rather than testing each mediator 
one by one in separate models. In the final path model, 
we included all pathways for which the indirect asso-
ciation of X with Y through M was significant. If the 
interaction between X and M was significant at p<0.05, 
we stratified the sample at the median of the inde-
pendent variable and tested the indirect association of 
X through M at both high and low levels of X. If the 
indirect association was significant at both high and low 
levels of X, then we retained the pathway in the model; 
otherwise, we removed that pathway.
Finally, we ran the final path model using the sem 
command in Stata with the mlmv option to estimate the 
model on the full data set using maximum likelihood 
estimation for missing values. All models controlled 
for three covariates: randomly assigned trial group 
(LNS vs no LNS), child sex and child age at 18-month 
LAZ assessment. In the final models, we corrected p 
values for multiple comparisons using the Benjami-
ni-Hochberg correction,27 which is recommended for 
controlling the false discovery rate in structural equa-
tion models.28 We applied the correction separately for 
each model (ie, for each cohort). If any pathway was 
not significant at corrected p<0.05, then we did not 
draw that pathway in the path diagram.
For objective 3, we examined the 16 variables 
that were available in all four cohorts: household 
asset index, household food insecurity access index, 
maternal and paternal education, household water 
and toilet, maternal age, height, and BMI, child diar-
rhoea and fever prevalence, child 6-month or 9-month 
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Hb and ZPP, mean dietary diversity across time points, 
variety of play materials and activities with caregivers 
at age 18 months. We report the R2 in the models with 
these 16 predictors in each cohort separately and in the 
pooled model to determine whether the pooled anal-
ysis accounted for more variance in 18-month LAZ than 
the within-cohort models.
resulTs
Summary statistics for all independent variables are 
presented in online supplementary table 2. The variable 
selection results are shown in online supplementary table 
3-6. The pathway selection results are shown in online 
supplementary table 7-10. At age 18 months, the mean 
(SD) LAZ in each cohort was −0.8 (1.0) in DYAD-G, −1.7 
(1.1) in DYAD-M, −1.9 (1.1) in DOSE and −1.5 (1.1) in 
ZINC. The percentage of children who were stunted 
(LAZ < −2) at age 18 months in each cohort was 12% 
in DYAD-G, 31% in DYAD-M, 43% in DOSE and 32% in 
ZINC.
Among environmental variables, 18-month LAZ 
was positively associated with higher household assets 
(DYAD-G), household being located closer to the market 
(DOSE), higher maternal education (DOSE, ZINC), 
higher paternal education (DYAD-M) and an improved 
water source (DOSE, ZINC). Of the maternal variables, 
we observed higher LAZ among children of mothers who 
were taller in all four cohorts and among children of 
mothers who had higher BMI in three cohorts (DYAD-M, 
DOSE, ZINC). In DYAD-G, higher LAZ was associated 
with higher maternal Hb at ≤20 weeks gestation. Among 
the caregiving variables, we observed higher LAZ among 
children who had greater dietary diversity (at 15 months 
in DOSE and at 9 months in ZINC), higher 18-month 
variety of play materials (DYAD-M, ZINC) or higher 
18-month activities with caregivers (DYAD-M).
Of the child variables, higher LAZ was associated with 
higher Hb at 6 (DYAD-M, DOSE) or 9 months (ZINC), 
greater positive change in Hb from 9 to 18 months 
(ZINC), lower 18-month AGP (DYAD-M), lower diar-
rhoea incidence from 6 (DOSE) or 9 (ZINC) to 18 
months, lower prevalence of poor appetite from 6 to 18 
months (DYAD-G) and higher activity levels as measured 
by accelerometer mean vector magnitude at 18 months 
(DOSE). In the two cohorts enrolled before birth, both 
gestational age at birth and LGAZ at birth were strongly 
associated with 18-month LAZ. All coefficients in the 
final models are presented in figure 4 and online supple-
mentary table 11 .
Regarding pathway (1), examination of genetic effects 
or intergenerational effects of maternal growth during 
early life, reflected by maternal adult height, on child 
18-month LAZ consistently showed that this was largely a 
direct association (66%–99% of the association between 
maternal height and LAZ across the four cohorts) 
rather than via mediation by other factors. In the two 
cohorts in which length at birth was measured, LGAZ 
at birth mediated a substantial proportion of this asso-
ciation (34% in DYAD-G, 30% in DYAD-M). A very small 
proportion of this association was mediated by child Hb 
at 6 months (2% in DOSE) or dietary diversity in infant 
feeding (1% in ZINC).
For pathway (2), the extent to which socioeconomic 
disparities were mediated by other factors varied across 
cohorts and independent variables, from 0% to 43%. 
In ZINC, the association of maternal education with 
18-month LAZ was mediated by the child’s variety of play 
materials (43%) and the association of improved water 
source with LAZ was not mediated by any other vari-
ables. In DYAD-G, the association between household 
assets and child LAZ was partly mediated by maternal 
lower Hb concentration in early pregnancy (17%) and 
gestational age at birth (11%). In DOSE, three envi-
ronmental variables were associated with LAZ: distance 
to the nearest market, maternal education and an 
improved water source. The direct proportion of these 
associations ranged from 74% to 93%. The association 
of distance to the nearest market with LAZ was partly 
mediated by maternal BMI (11%) and child diarrhoea 
incidence (5%). The association of maternal education 
with 18-month LAZ was partly mediated by maternal BMI 
(7%). The association of improved water source with 
child LAZ was partly mediated by child physical activity 
(26%). In DYAD-M, while the association of paternal 
education with LAZ was retained in the variable selection 
process, it was not significant in the final model and was 
not mediated by any variables.
Regarding pathway (3), the extent to which associations 
of maternal health and nutritional status with child LAZ 
were mediated versus direct effects also varied by cohort 
and independent variable (0%–56%). In DYAD-M, the 
association between maternal BMI and 18-month LAZ 
was largely mediated by LGAZ at birth (62%). In the two 
cohorts in which LGAZ at birth was not available, the 
association of maternal BMI with LAZ was largely a direct 
association (92%–94%), with a small proportion medi-
ated by the child’s variety of play materials (8% in ZINC) 
or child Hb concentration at 6 months (6% in DOSE). 
In DYAD-G, the association of maternal Hb in early preg-
nancy with 18-month LAZ was not mediated by any other 
variables.
Associations of dietary diversity in infant feeding at 9 
months in ZINC and 15 months in DOSE with 18-month 
LAZ (pathway 4.1) were partly mediated by child diar-
rhoea incidence. Caregivers who reported higher dietary 
diversity in infant feeding also reported higher diarrhoea 
incidence in the child. The association of dietary diversity 
with 18-month LAZ was also positive and the association 
of diarrhoea incidence with 18-month LAZ was negative; 
therefore, the proportion of the association between 
dietary diversity and child LAZ that was mediated by diar-
rhoea incidence was negative (−5% in ZINC and −28% 
in DOSE).
Results from both trials that measured gestational 
age and length at birth showed that these were direct 
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Figure 4 Path diagram of factors associated with18-month LAZ in four iLiNS cohorts. 1Measured in one cohort. 2Measured 
in two cohorts. 3Measured in three cohorts. AGP, alpha-1-acid glycoprotein; BMI, body mass index; Hb, haemoglobin; iLiNS 
International Lipid-Based Nutrient Supplements; LAZ, length-for-age z-score.
associations, unmediated by any other child factors 
(pathway 5.2). The following results from the ZINC 
cohort supported pathway (6.1): children with lower Hb 
at age 9 months were provided with lower variety of play 
materials at 18 months, mediating 12% of the association 
with 18-month LAZ. Similar to dietary diversity, variety 
of play materials was positively associated with diarrhoea 
incidence, therefore this mediated −8% of the negative 
association between diarrhoea incidence and child LAZ.
The final models accounted for 34% of the variance 
in 18-month LAZ in DYAD-G, 37% in DYAD-M, 17% in 
DOSE and 20% in ZINC. Overall, maternal and child 
factors showed stronger associations with 18-month LAZ 
compared with environmental and caregiving factors, 
even when considering both indirect and direct effects 
(figure 5).
For objective 3, the 16 variables common across all 
four cohorts accounted for the following percentage 
of variance in 18-month LAZ: 16% in DYAD-G, 21% in 
DYAD-M, 15% in DOSE, 19% in ZINC, and 25% in the 
pooled analysis. Of these 16 variables, maternal height 
accounted for the largest proportion of variance in 
18-month LAZ: 11% in DYAD-G, 14% in DYAD-M, 10% 
in DOSE, 11% in ZINC and 9% in the pooled analysis. 
Therefore, excluding maternal height, environmental, 
maternal, caregiving and child factors accounted for only 
5%–8% of variance in LAZ in the individual cohorts and 
16% in the pooled analysis.
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Figure 5 Coefficients of direct and indirect effects on 18-month LAZ in the final structural equation models. BMI, body mass 
index; Hb, haemoglobin; LAZ, length-for-age z-score.
dIsCussIon
In four prospective cohorts of children, we conducted 
path analyses of environmental, maternal, caregiving and 
child factors hypothesised to be associated with 18-month 
linear growth status. Out of 42 indicators examined, only 
2 indicators emerged as consistent predictors of 18-month 
LAZ in 3–4 cohorts: maternal height and maternal BMI. 
Two additional factors, which were only measured in the 
two pregnancy cohorts, were significantly associated with 
18-month LAZ in both cohorts in which they were meas-
ured: LGAZ at birth and gestational age at birth. In the 
two cohorts enrolled after birth, four factors were signif-
icantly associated with 18-month LAZ in both cohorts: 
improved household water source, dietary diversity in 
infant feeding, childhood diarrhoea incidence and 
6-month or 9-month Hb. Overall, maternal and child 
factors showed stronger and more consistent associa-
tions with child LAZ than environmental and caregiving 
factors, even when considering both indirect and direct 
effects.
While specific pathways differed across cohorts, in 
general direct associations were stronger and more prev-
alent than indirect associations. The strongest evidence 
for mediation was the finding that 62% of the association 
of maternal BMI with 18-month LAZ was mediated by 
LGAZ at birth in DYAD-M. This underscores the impor-
tance of maternal nutritional status for fetal growth, with 
lasting consequences for growth status later in childhood. 
LGAZ at birth also mediated a substantial proportion of 
the association of maternal height with 18-month LAZ 
(30%–34%) in both cohorts in which it was measured 
(DYAD-M and DYAD-G). This pathway is likely to reflect 
genetic influences, at least in part, and therefore may be 
only partly modifiable. In the two cohorts in which LAZ 
at birth was not measured (DOSE and ZINC), the associ-
ation of maternal height with 18-month LAZ was a direct 
association.
Of the eight key risk factors closely associated with linear 
growth faltering that we found, three were consistently 
identified in previous studies that examined the relative 
contribution of risk factors to stunting prevalence glob-
ally: fetal growth restriction, diarrhoea and low dietary 
diversity. Danaei et al used population surveys to estimate 
cases of stunting attributable to 18 risk factors in 137 
developing countries, including indicators of maternal 
nutrition and infection, teenage motherhood and short 
birth intervals, fetal growth restriction and preterm birth, 
child nutrition and infection, and environmental factors. 
They found that a large number of stunting cases were 
attributable to being born small for gestational age at term 
(10.8 million, 24% of cases), followed by poor sanitation 
(7.2 million, 16% of cases) and diarrhoea (5.8 million, 
13% of cases).11 In a systematic review, Mosites et al calcu-
lated the population-attributable fraction of stunting for 
five categories of risk factors: low birth weight, insuffi-
cient diet, enteric dysfunction, infection and toxin expo-
sure. They estimated that 25% of global stunting could 
be attributed to child diarrhoea incidence. In Africa, the 
largest number of stunting cases was attributable to low 
dietary diversity, low feeding frequency, or both (30%).12 
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Another study using population-based surveys from 54 
countries estimated that mothers in the lowest category 
of height (<145 cm) were 2.1 times more likely to have 
stunted children than mothers in the highest category 
(≥160 cm).8
The key risk factors for linear growth faltering that 
we identified were similar to those identified in these 
studies despite several differences in methodology, 
including prospective cohorts rather than cross-sectional 
design, examination of both direct and indirect associ-
ations through path analysis, and examination of LAZ 
as a continuous variable rather than stunting cases. By 
analysing associations with LAZ, we were able to estimate 
the difference in LAZ with each SD change in predictor 
variables. Each SD difference in maternal height (5–6 
cm) was associated with 0.25 difference in LGAZ at birth 
(0.5 cm) and a 0.2–0.3 difference in child 18-month LAZ 
(0.5–0.8 cm). Each SD difference in LGAZ at birth (1.9 
cm) was associated with about a 0.5 difference in child 
18-month LAZ (1.4 cm). Each SD difference in gesta-
tional age at birth (1.8 weeks) was associated with a 
0.13–0.17 difference in 18-month LAZ (0.3–0.5 cm). The 
coefficient sizes for the other key risk factors (maternal 
BMI, improved water source, dietary diversity, child diar-
rhoea and Hb) were smaller in magnitude (0.06–0.12).
Despite the examination of 42 environmental, 
maternal, caregiving and child factors measured longi-
tudinally throughout most of the first 1000 days, our 
models accounted for a relatively small proportion of 
the variance in 18-month LAZ (17%–37%), and a large 
proportion of that was due to maternal height (10%–
14%). Factors that were not associated with LAZ were 
indicators of maternal iron status, illness and inflamma-
tion during pregnancy, maternal stress, depression and 
cognition, exclusive breast feeding during 6 months post 
partum, infant feeding frequency and child fever, malaria 
and acute respiratory infections. Variance that remained 
unaccounted for could be due to unmeasured factors, 
such as enteric dysfunction, asymptomatic infections, 
microbiome composition, maternal HIV status or aspects 
of the diet that were not assessed. It is also possible that 
population-level factors, such as community sanitation or 
access to healthcare, may be stronger drivers of growth 
stunting compared with individual or household-level 
factors.
Our finding that the pooled analysis accounted for more 
variance in LAZ (25%) compared with separate anal-
yses by cohort (11%–21%) also supports this argument, 
although this difference is not very large. Excluding the 
variance accounted for by maternal height, the pooled 
analysis accounted for two to three times the variance in 
LAZ (16%) compared with the separate cohort models 
(5%–8%). This may be due to the lack of inclusion of 
a cohort experiencing healthy growth. All four iLiNS 
cohorts experienced growth faltering, although the 
cohorts in Malawi and Burkina Faso had faltered 1.5–1.9 
SD below the WHO median on average, compared with 
the Ghanaian children whose mean LAZ was only 0.8 
SD below the WHO median by age 18 months. Another 
potential reason is that we did not measure communi-
ty-level or social factors that may contribute to children’s 
growth faltering at a population level. For example, 
several studies have found that community-level sanita-
tion coverage predicts child growth more strongly than 
household-level sanitation.29 30
Strengths of the study were the large number of chil-
dren in each cohort, the large number of variables 
examined and the availability of data from four cohorts 
of children in three African countries, with many vari-
ables harmonised across cohorts, enabling the examina-
tion of the same factors and pathways across contexts. 
Another strength was that the cohorts were enrolled 
either during pregnancy or at 6 or 9 months post 
partum and followed prospectively through 18 months 
post partum, allowing these risk factors to be examined 
throughout a large portion of the first 1000 days after 
conception. The prospective design allowed associations 
in the path model to be drawn from variables measured 
at earlier time points (eg, pregnancy, birth) to variables 
measured at later time points (eg, 6 months, 18 months), 
reducing the risk of reverse causality. However, this does 
not prevent the possibility of residual confounding, that 
is, unmeasured variables accounting for observed asso-
ciations, therefore we are not able to establish causality. 
Another limitation was that we were not able to explore 
certain risk factors, such as asymptomatic infections or 
enteric dysfunction. We reported multiple comparisons; 
therefore, may have found some false positive associa-
tions due to chance. However, we reduced this possibility 
by reporting p values corrected for multiple comparisons 
and by basing our primary conclusions on findings that 
were replicated in more than one cohort. These samples 
may not be representative of their populations due to 
their participation in the nutritional supplementation 
trials. However, any bias introduced by the supplementa-
tion would be expected to decrease rather than increase 
the strength of the associations.31 Therefore, our conclu-
sions regarding consistent significant associations would 
remain the same.
ConClusIon
Our findings may help to inform the design of interven-
tions to pursue United Nations’ Sustainable Development 
Goal 2, to end hunger and achieve improved nutrition 
by 2030, with the reduction of stunting prevalence as a 
key indicator of progress towards this goal. The evidence 
we present shows that child linear growth status is closely 
linked to higher maternal height and BMI, fetal growth, 
full-term birth, improved household water supply, higher 
child dietary diversity, Hb during infancy and reduced 
childhood diarrhoea incidence, but we did not find 
associations with maternal iron status, illness and inflam-
mation during pregnancy (including maternal HIV 
infection in the one cohort in which it was measured), 
maternal stress and depression, exclusive breastfeeding 
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during 6 months post partum, infant feeding frequency 
or child fever, malaria and acute respiratory infections. 
Much of the variance in linear growth status remained 
unaccounted for by the 42 individual-level factors meas-
ured in this study, suggesting that interventions targeting 
other individual-level factors or community-level changes 
may be needed to achieve substantial progress in stunting 
reduction. The large amount of unexplained variance 
also suggests that further research is needed to under-
stand the causes of linear growth faltering in order to 
design more effective strategies to reach the WHO’s 
target to achieve a 40% reduction in the number of chil-
dren under-5 who are stunted by 2025.
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